nach oben

Reactions Weekly

Erschienen in:

01.03.2017 | Case report

Meglumine-antimonate

Drug allergy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

A 39-year-old woman developed drug allergy during treatment with meglumine antimonate injection [Glucantim] for leishmaniasis [dosages not stated]. After five injections, she developed allergy. Subsequently, the therapy was discontinued [time to reaction onset and outcome not stated]. …

Sadeghian G, et al. Treatment of glucantimTM-resistant cutaneous leishmaniasis using combination therapy of allopurinol and trichloroacetic acid (TCA) 50%; report of three cases. Journal of Isfahan Medical School 34: 1318-1322, No. 405, Jan 2017. Available from: URL: http://jims.mui.ac.ir/index.php/jims/article/view/7338 [Persian; summarised from a translation] - Iran

Titel: Meglumine-antimonate
Drug allergy: case report
Publikationsdatum: 01.03.2017
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-017-27966-x

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Meglumine-antimonate

Drug allergy: case report

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2017

Aspirin

Hydroxycarbamide/interferon-α-2

Antineoplastics

NSAIDs

Ribavirin

Ketamine overdose